Literature DB >> 11686922

Dissociation of m-calpain subunits occurs after autolysis of the N-terminus of the catalytic subunit, and is not required for activation.

K Nakagawa1, H Masumoto, H Sorimachi, K Suzuki.   

Abstract

Calpain is a heterodimeric, intracellular Ca(2+)-dependent, "bio-modulator" that alters the properties of substrates through site-specific proteolysis. It has been proposed that calpains are activated by autolysis of the N-terminus of the large subunit and/or its dissociation into the subunits. It is, however, unclear whether the dissociation into subunits is required for the expression of protease activity and/or for in vivo function. Recently, the crystal structure of m-calpain in the absence of Ca(2+) has been resolved. The 3D structure clearly shows that the N-terminus of the m-calpain large subunit (mCL) makes contact with the 30K subunit, suggesting that autolysis of the N-terminus of mCL changes the interaction of both subunits. To examine the relationship between autolysis, dissociation, and activation, we made and analysed a series of N-terminal mutants of mCL that mimic the autolysed forms or have substituted amino acid residue(s) interacting with 30K. As a result, the mutant m-calpains, which are incapable of autolysis, did not dissociate into subunits, whereas those lacking the N-terminal 19 residues (Delta 19), but not those lacking only nine residues (Delta 9), dissociated into subunits even in the absence of Ca(2+). Moreover, both Delta 9 and Delta 19 mutants showed an equivalent reduced Ca(2+) requirement for protease activity. These results indicate that autolysis is necessary for the dissociation of the m-calpain subunits, and that the dissociation occurs after, but is not necessary for, activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686922     DOI: 10.1093/oxfordjournals.jbchem.a003025

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

Review 1.  Calpain and synaptic function.

Authors:  Hai-Yan Wu; David R Lynch
Journal:  Mol Neurobiol       Date:  2006-06       Impact factor: 5.590

Review 2.  Calpain-2 as a therapeutic target for acute neuronal injury.

Authors:  Yubin Wang; Xiaoning Bi; Michel Baudry
Journal:  Expert Opin Ther Targets       Date:  2017-11-28       Impact factor: 6.902

3.  A Gastrointestinal Calpain Complex, G-calpain, Is a Heterodimer of CAPN8 and CAPN9 Calpain Isoforms, Which Play Catalytic and Regulatory Roles, Respectively.

Authors:  Shoji Hata; Fujiko Kitamura; Midori Yamaguchi; Hiroshi Shitara; Makoto Murakami; Hiroyuki Sorimachi
Journal:  J Biol Chem       Date:  2016-11-23       Impact factor: 5.157

4.  Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain.

Authors:  Previn Dutt; Cherie N Spriggs; Peter L Davies; Zongchao Jia; John S Elce
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

5.  Characterization of a new p94-like calpain form in human lymphocytes.

Authors:  Roberta De Tullio; Roberto Stifanese; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 6.  Targeting calpain in synaptic plasticity.

Authors:  Michel Baudry; Maggie M Chou; Xiaoning Bi
Journal:  Expert Opin Ther Targets       Date:  2013-02-04       Impact factor: 6.902

7.  Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells.

Authors:  Huanjie Yang; Shalini Murthy; Fazlul H Sarkar; Shijie Sheng; G Prem-Veer Reddy; Q Ping Dou
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

Review 8.  Calpain chronicle--an enzyme family under multidisciplinary characterization.

Authors:  Hiroyuki Sorimachi; Shoji Hata; Yasuko Ono
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

9.  Calpain-2 participates in the process of calpain-1 inactivation.

Authors:  Fumiko Shinkai-Ouchi; Mayumi Shindo; Naoko Doi; Shoji Hata; Yasuko Ono
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.